Clinical Trials & Emerging Therapies in Chronic Kidney Disease
Clinical trials in Chronic Kidney Disease (CKD) focus on SGLT2 inhibitors, GLP-1 receptor agonists, and anti-fibrotic therapies to slow progression. Emerging innovations include regenerative medicine, precision therapies, and AI-driven management to preserve kidney function and improve care.